Cholesterol Drug: 31% Lower Heart Attack Risk

Evolocumab Shows Promise in Preventing First Heart Attacks and Strokes in Diabetics February 29, 2024 Groundbreaking research suggests a powerful cholesterol-lowering medication, evolocumab, could redefine heart disease prevention, particularly for individuals with diabetes at high risk. The findings indicate the drug significantly reduces the likelihood of experiencing a first-time heart attack or stroke, even before … Read more